Table 1.
Specimen and treatment† | Day post-treatment | |||
---|---|---|---|---|
Day 0 | Day 2 | Day 4 | Day 6 | |
Untreated oral fluid | ||||
Negative | 0.0 (0.1) | 0.0 (0.1) | 0.0 (0.0) | 0.0 (0.0) |
Positive | 1.4 (1.2) | 1.5 (1.3) | 1.4 (0.1) | 1.1 (0.9) |
Oral fluid treatment A | ||||
Negative | 0.0 (0.1) | 0.0 (0.1) | 0.0 (0.1) | 0.0 (0.1) |
Positive | 1.0 (0.9) | 1.0 (1.0) | 1.1 (1.0) | 0.9 (1.1) |
Oral fluid treatment B | ||||
Negative | 0.0 (0.1) | 0.0 (0.1) | 0.0 (0.1) | 0.0 (0.1) |
Positive | 1.2 (1.1) | 1.4 (1.3) | 1.3 (1.1) | 1.1 (0.8) |
Oral fluid treatment C | ||||
Negative | 0.0 (0.1) | 0.0 (0.1) | 0.0 (0.1) | 0.0 (0.1) |
Positive | 1.0 (0.9) | 1.1 (1.0) | 1.0 (1.0) | 0.9 (0.9) |
Serum (no treatment) | ||||
Negative | 0.1 (0.2) | 0.1 (0.2) | 0.1 (0.2) | 0.1 (0.2) |
Positive | 1.9 (0.5) | 1.8 (0.5) | 1.7 (0.5) | 2.2 (0.7) |
Samples held at 4°C.
Pairwise comparisons of IgG S/P ratios at 0 days post-treatment (DPT) versus 2, 4, and 6 DPT results detected no differences in IgG ELISA S/P ratios over time (p > 0.05).